Joel A. Okoli to Aged
This is a "connection" page, showing publications Joel A. Okoli has written about Aged.
Connection Strength
0.125
-
Bumpers HL, Tadros T, Gabram-Mendola S, Rizzo M, Martin M, Zaremba N, Okoli J. Phyllodes tumors in African American women. Am J Surg. 2015 Jul; 210(1):74-9.
Score: 0.056
-
Jones V, Linebarger J, Perez S, Gabram S, Okoli J, Bumpers H, Burns B, Mosunjac M, Rizzo M. Excising Additional Margins at Initial Breast-Conserving Surgery (BCS) Reduces the Need for Re-excision in a Predominantly African American Population: A Report of a Randomized Prospective Study in a Public Hospital. Ann Surg Oncol. 2016 Feb; 23(2):456-64.
Score: 0.014
-
Bowman E, Oprea G, Okoli J, Gundry K, Rizzo M, Gabram-Mendola S, Manne U, Smith G, Pambuccian S, Bumpers HL. Pseudoangiomatous stromal hyperplasia (PASH) of the breast: a series of 24 patients. Breast J. 2012 May-Jun; 18(3):242-7.
Score: 0.011
-
Rizzo M, Bumpers H, Okoli J, Senior-Crosby D, O'Regan R, Zelnak A, Pan L, Mosunjac M, Patterson SG, Gabram SG. Improving on national quality indicators of breast cancer care in a large public hospital as a means to decrease disparities for African American women. Ann Surg Oncol. 2011 Jan; 18(1):34-9.
Score: 0.010
-
Iyengar R, Lund MJ, Lamson P, Holmes L, Rizzo M, Bumpers H, Okoli J, Senior-Crosby D, O'Regan R, Gabram SG. Using National Quality Forum breast cancer indicators to measure quality of care for patients in an AVON comprehensive breast center. Breast J. 2010 May-Jun; 16(3):240-4.
Score: 0.010
-
Lund MJ, Butler EN, Bumpers HL, Okoli J, Rizzo M, Hatchett N, Green VL, Brawley OW, Oprea-Ilies GM, Gabram SG. High prevalence of triple-negative tumors in an urban cancer center. Cancer. 2008 Aug 01; 113(3):608-15.
Score: 0.009
-
Crump SR, Shipp MP, McCray GG, Morris SJ, Okoli JA, Caplan LS, Thorne SL, Blumenthal DS. Abnormal mammogram follow-up: do community lay health advocates make a difference? Health Promot Pract. 2008 Apr; 9(2):140-8.
Score: 0.009
-
Aikhionbare FO, Khan M, Carey D, Okoli J, Go R. Is cumulative frequency of mitochondrial DNA variants a biomarker for colorectal tumor progression? Mol Cancer. 2004 Oct 13; 3:30.
Score: 0.007